2.1:

Pharmacovigilance

JoVE 핵심
Pharmacology
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.  전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
JoVE 핵심 Pharmacology
Pharmacovigilance

441 Views

01:19 min

September 22, 2023

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.

This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.

In some cases, there might be a legal obligation to report potential adverse effects. These reported data are then examined for 'signals,' which are potential causal links between the drug and the reported adverse event that were not identified earlier. For validation of these signals, a causality assessment is performed. It involves examining various elements, such as the temporal relationship between drug administration and the ADR, the pharmacological plausibility of the reaction, and the outcomes of dechallenge and rechallenge tests.

Post-evaluation, the causality is classified as definite, probable, possible, or unlikely. Regulatory bodies flag drugs exhibiting adverse effects. These findings are disseminated through channels like drug alerts, medical journals, and updates to drug labels with suitable warnings or precautions. In severe cases, the drug may be removed from the market.